Intellia Therapeutics Inc

XNAS: NTLA

Weak Stock

Download real time

7.46 0.05 (0.67%)

New 52W Low in past week

1.1M XNAS Volume

XNAS 14 Apr, 2025 1:23 PM (EDT)

772.2

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Intellia Therapeutics Inc - NTLA - stock price prediction, stock price target, analyst ratings from 29 analysts

Intellia Therapeutics Inc has a share price target of US$ 44, revenue growth forecast of -17.9%, and profit growth estimate of 6.8% for FY25, based on top 29 analyst calls.

Forecaster Screeners